VALLEY FORGE, Pa. One of the world's largest pharmaceutical services companies has announced organizational changes effective Sept. 1.
AmerisourceBergen said late Monday that Steven H. Collis will become EVP at AmerisourceBergen and president of AmerisourceBergen Drug Corp., the company's largest subsidiary. Collis was previously EVP and president AmerisourceBergen Specialty Group. He led ABSG from a start-up company in 1994 to the approximately $15 billion subsidiary it is today. In his new role, he will lead the ABDC organization. He continues to report directly to R. David Yost, the company's president and CEO.
Additional shifts include Michael A. Mullen as COO of ABSG, also reporting directly to Yost. Prior to his new assignment, Mullen, who has been with ABSG for six years, was president distribution services at ABSG, previously served as the CFOr for the subsidiary, and has been a key force behind the long-running success of ABSG.
"ABDC has been very successful since we began running it with executive vice president and chief financial officer Mike DiCandilo leading operations and me leading sales and marketing," said Yost. "To drive future performance, we are consolidating those functions under one leader, and I am very pleased that Steve Collis will be applying his substantial management talent to lead ABDC. At the same time, Mike DiCandilo [AmerisourceBergen's EVP and CFO] will continue his corporate role with ABDC in finance, supply chain management and our very important Business Transformation ERP project. The result will be an even more focused organization."